These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 28697571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice.
    Yang RY, Zhao G, Wang DM, Pang XC, Wang SB, Fang JS, Li C, Liu AL, Wu S, Du GH.
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):15-26. PubMed ID: 26476132
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX, Chen DF.
    Brain Res; 2015 Nov 19; 1627():177-88. PubMed ID: 26423933
    [Abstract] [Full Text] [Related]

  • 6. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    Akhter H, Huang WT, van Groen T, Kuo HC, Miyata T, Liu RM.
    J Alzheimers Dis; 2018 Nov 19; 64(2):447-457. PubMed ID: 29914038
    [Abstract] [Full Text] [Related]

  • 7. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y.
    Aging Cell; 2017 Oct 19; 16(5):1073-1082. PubMed ID: 28771976
    [Abstract] [Full Text] [Related]

  • 8. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J, Wang JX, Du YH, Liu Y, Zhang W, Chen JF, Liu YJ, Zheng M, Wang KJ, He GQ.
    CNS Neurosci Ther; 2018 Dec 19; 24(12):1207-1218. PubMed ID: 29869390
    [Abstract] [Full Text] [Related]

  • 9. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N, Liu CC, Shinohara M, Frisch-Daiello J, Ma L, Yamazaki Y, Tachibana M, Younkin L, Kurti A, Carrasquillo MM, Zou F, Sevlever D, Bisceglio G, Gan M, Fol R, Knight P, Wang M, Han X, Fryer JD, Fitzgerald ML, Ohyagi Y, Younkin SG, Bu G, Kanekiyo T.
    J Neurosci; 2016 Mar 30; 36(13):3848-59. PubMed ID: 27030769
    [Abstract] [Full Text] [Related]

  • 10. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
    Zhang B, Tang XC, Zhang HY.
    J Neurosci Res; 2013 May 30; 91(5):717-25. PubMed ID: 23401344
    [Abstract] [Full Text] [Related]

  • 11. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z, Wang C, He W, Chen Y.
    Curr Alzheimer Res; 2018 May 30; 15(11):1045-1052. PubMed ID: 29962345
    [Abstract] [Full Text] [Related]

  • 12. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS, Shen LL, Bu XL, Zhang WW, Chen SH, Huang ZL, Xiong JX, Gao CY, Dong Z, He YN, Hu ZA, Zhou HD, Song W, Zhou XF, Wang YZ, Wang YJ.
    Acta Neuropathol; 2017 Aug 30; 134(2):207-220. PubMed ID: 28477083
    [Abstract] [Full Text] [Related]

  • 13. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 14. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D, Zhao Y, Qi Y, Gao Y, Tu D, Wang Y, Gao HM, Zhou H.
    J Neuroinflammation; 2020 Aug 31; 17(1):258. PubMed ID: 32867800
    [Abstract] [Full Text] [Related]

  • 15. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC.
    Exp Neurol; 2015 May 31; 267():219-29. PubMed ID: 25747037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.
    J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
    Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L.
    J Biol Chem; 2010 Nov 19; 285(47):36958-68. PubMed ID: 20847045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.